A detailed history of Canopy Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Canopy Partners, LLC holds 2,567 shares of AMGN stock, worth $678,945. This represents 0.36% of its overall portfolio holdings.

Number of Shares
2,567
Previous 2,561 0.23%
Holding current value
$678,945
Previous $800 Million 3.37%
% of portfolio
0.36%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$309.38 - $337.38 $1,856 - $2,024
6 Added 0.23%
2,567 $827 Million
Q2 2024

Aug 09, 2024

BUY
$262.75 - $319.31 $8,145 - $9,898
31 Added 1.23%
2,561 $800 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $16,938 - $20,447
63 Added 2.55%
2,530 $719 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $630,811 - $711,630
2,467 New
2,467 $711 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Canopy Partners, LLC Portfolio

Follow Canopy Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canopy Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canopy Partners, LLC with notifications on news.